Kaplan Brett 4
4 · Compass Therapeutics, Inc. · Filed Sep 14, 2020
Insider Transaction Report
Form 4
Kaplan Brett
Director
Transactions
- Award
Stock Option (Right to Buy)
2020-09-10+60,000→ 60,000 totalExercise: $5.00Exp: 2030-09-10→ Common Stock (60,000 underlying)
Footnotes (1)
- [F1]This option shall vest in substantially equal monthly installments over four years.